Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Eric P. Krenning, James C. Yao et al.|New England Journal of Medicine|2017Cited by 3.2k
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patientsDik J. Kwekkeboom, Eric P. Krenning, Willem H. Bakker et al.|European Journal of Nuclear Medicine and Molecular Imaging|2001Cited by 471